Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.

<h4>Background</h4>Conflicts of interest in biomedical research can influence research results and drive research agendas away from public health priorities. Previous agenda-setting studies share two shortfalls: they only account for direct connections between academic institutions and f...

Full description

Saved in:
Bibliographic Details
Main Authors: Federico E Testoni, Mercedes García Carrillo, Marc-André Gagnon, Cecilia Rikap, Matías Blaustein
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249661&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850181683421118464
author Federico E Testoni
Mercedes García Carrillo
Marc-André Gagnon
Cecilia Rikap
Matías Blaustein
author_facet Federico E Testoni
Mercedes García Carrillo
Marc-André Gagnon
Cecilia Rikap
Matías Blaustein
author_sort Federico E Testoni
collection DOAJ
description <h4>Background</h4>Conflicts of interest in biomedical research can influence research results and drive research agendas away from public health priorities. Previous agenda-setting studies share two shortfalls: they only account for direct connections between academic institutions and firms, as well as potential bias based on researchers' personal beliefs. This paper's goal is to determine the key actors and contents of the prevailing health and biomedical sciences (HBMS) research agenda, overcoming these shortfalls.<h4>Methods</h4>We performed a bibliometric and lexical analysis of 95,415 scientific articles published between 1999 and 2018 in the highest impact factor journals within HBMS, using the Web of Science database and the CorText platform. HBMS's prevailing knowledge network of institutions was proxied with network maps where nodes represent affiliations and edges the most frequent co-authorships. The content of the prevailing HBMS research agenda was depicted through network maps of prevalent multi-terms found in titles, keywords, and abstracts.<h4>Results</h4>The HBMS research agendas of large private firms and leading academic institutions are intertwined. The prevailing HBMS agenda is mostly based on molecular biology (40% of the most frequent multi-terms), with an inclination towards cancer and cardiovascular research (15 and 8% of the most frequent multi-terms, respectively). Studies on pathogens and biological vectors related to recent epidemics are marginal (1% of the most frequent multi-terms). Content of the prevailing HBMS research agenda prioritizes research on pharmacological intervention over research on socio-environmental factors influencing disease onset or progression and overlooks, among others, the study of infectious diseases.<h4>Conclusions</h4>Pharmaceutical corporations contribute to set HBMS's prevailing research agenda, which is mainly focused on a few diseases and research topics. A more balanced research agenda, together with epistemological approaches that consider socio-environmental factors associated with disease spreading, could contribute to being better prepared to prevent and treat more diverse pathologies and to improve overall health outcomes.
format Article
id doaj-art-d0cd7acc1bfc43739aadc8cc7f209e95
institution OA Journals
issn 1932-6203
language English
publishDate 2021-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-d0cd7acc1bfc43739aadc8cc7f209e952025-08-20T02:17:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01164e024966110.1371/journal.pone.0249661Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.Federico E TestoniMercedes García CarrilloMarc-André GagnonCecilia RikapMatías Blaustein<h4>Background</h4>Conflicts of interest in biomedical research can influence research results and drive research agendas away from public health priorities. Previous agenda-setting studies share two shortfalls: they only account for direct connections between academic institutions and firms, as well as potential bias based on researchers' personal beliefs. This paper's goal is to determine the key actors and contents of the prevailing health and biomedical sciences (HBMS) research agenda, overcoming these shortfalls.<h4>Methods</h4>We performed a bibliometric and lexical analysis of 95,415 scientific articles published between 1999 and 2018 in the highest impact factor journals within HBMS, using the Web of Science database and the CorText platform. HBMS's prevailing knowledge network of institutions was proxied with network maps where nodes represent affiliations and edges the most frequent co-authorships. The content of the prevailing HBMS research agenda was depicted through network maps of prevalent multi-terms found in titles, keywords, and abstracts.<h4>Results</h4>The HBMS research agendas of large private firms and leading academic institutions are intertwined. The prevailing HBMS agenda is mostly based on molecular biology (40% of the most frequent multi-terms), with an inclination towards cancer and cardiovascular research (15 and 8% of the most frequent multi-terms, respectively). Studies on pathogens and biological vectors related to recent epidemics are marginal (1% of the most frequent multi-terms). Content of the prevailing HBMS research agenda prioritizes research on pharmacological intervention over research on socio-environmental factors influencing disease onset or progression and overlooks, among others, the study of infectious diseases.<h4>Conclusions</h4>Pharmaceutical corporations contribute to set HBMS's prevailing research agenda, which is mainly focused on a few diseases and research topics. A more balanced research agenda, together with epistemological approaches that consider socio-environmental factors associated with disease spreading, could contribute to being better prepared to prevent and treat more diverse pathologies and to improve overall health outcomes.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249661&type=printable
spellingShingle Federico E Testoni
Mercedes García Carrillo
Marc-André Gagnon
Cecilia Rikap
Matías Blaustein
Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
PLoS ONE
title Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
title_full Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
title_fullStr Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
title_full_unstemmed Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
title_short Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda.
title_sort whose shoulders is health research standing on determining the key actors and contents of the prevailing biomedical research agenda
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0249661&type=printable
work_keys_str_mv AT federicoetestoni whoseshouldersishealthresearchstandingondeterminingthekeyactorsandcontentsoftheprevailingbiomedicalresearchagenda
AT mercedesgarciacarrillo whoseshouldersishealthresearchstandingondeterminingthekeyactorsandcontentsoftheprevailingbiomedicalresearchagenda
AT marcandregagnon whoseshouldersishealthresearchstandingondeterminingthekeyactorsandcontentsoftheprevailingbiomedicalresearchagenda
AT ceciliarikap whoseshouldersishealthresearchstandingondeterminingthekeyactorsandcontentsoftheprevailingbiomedicalresearchagenda
AT matiasblaustein whoseshouldersishealthresearchstandingondeterminingthekeyactorsandcontentsoftheprevailingbiomedicalresearchagenda